Cantel Medical Corp. (CMN) to Issue Semiannual Dividend of $0.07
Cantel Medical Corp. (NYSE:CMN) announced a semiannual dividend on Monday, October 17th. Stockholders of record on Tuesday, January 17th will be given a dividend of 0.07 per share on Tuesday, January 31st. This represents a dividend yield of 0.18%. The ex-dividend date is Thursday, January 12th. This is an increase from Cantel Medical Corp.’s previous semiannual dividend of $0.06.
Cantel Medical Corp. (NYSE:CMN) traded up 0.45% during mid-day trading on Monday, hitting $75.90. The stock had a trading volume of 103,730 shares. The stock has a market cap of $3.14 billion, a P/E ratio of 52.78 and a beta of 1.59. Cantel Medical Corp. has a one year low of $55.01 and a one year high of $81.63. The company has a 50 day moving average price of $77.84 and a 200 day moving average price of $71.26.
Cantel Medical Corp. (NYSE:CMN) last released its quarterly earnings data on Thursday, September 29th. The company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.11. The business earned $179 million during the quarter. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. The company’s quarterly revenue was up 18.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.39 earnings per share. On average, equities analysts anticipate that Cantel Medical Corp. will post $1.98 EPS for the current year.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/17/cantel-medical-corp-cmn-to-issue-semiannual-dividend-of-0-07.html
In related news, CAO Steven C. Anaya sold 5,500 shares of the stock in a transaction on Monday, October 10th. The stock was sold at an average price of $77.07, for a total value of $423,885.00. Following the completion of the sale, the chief accounting officer now directly owns 48,132 shares in the company, valued at approximately $3,709,533.24. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Ann E. Berman sold 1,453 shares of the stock in a transaction on Friday, September 30th. The shares were sold at an average price of $77.56, for a total value of $112,694.68. Following the completion of the sale, the director now owns 5,424 shares of the company’s stock, valued at $420,685.44. The disclosure for this sale can be found here. 15.30% of the stock is owned by corporate insiders.
A number of hedge funds have recently made changes to their positions in the stock. King Luther Capital Management Corp increased its stake in shares of Cantel Medical Corp. by 1.7% in the second quarter. King Luther Capital Management Corp now owns 204,145 shares of the company’s stock valued at $14,031,000 after buying an additional 3,385 shares in the last quarter. American International Group Inc. increased its stake in shares of Cantel Medical Corp. by 1.5% in the second quarter. American International Group Inc. now owns 26,669 shares of the company’s stock valued at $1,833,000 after buying an additional 400 shares in the last quarter. OMERS ADMINISTRATION Corp bought a new stake in shares of Cantel Medical Corp. during the second quarter valued at about $1,388,000. Janney Montgomery Scott LLC increased its stake in shares of Cantel Medical Corp. by 81.7% in the second quarter. Janney Montgomery Scott LLC now owns 7,838 shares of the company’s stock valued at $538,000 after buying an additional 3,524 shares in the last quarter. Finally, AXA bought a new stake in shares of Cantel Medical Corp. during the second quarter valued at about $1,252,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.
A number of research firms have recently commented on CMN. Needham & Company LLC began coverage on Cantel Medical Corp. in a report on Wednesday, August 24th. They set a “hold” rating for the company. Benchmark Co. began coverage on Cantel Medical Corp. in a report on Monday, August 29th. They set a “buy” rating and a $83.00 price objective for the company.
Cantel Medical Corp. Company Profile
Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.